Google DeepMind and South Korea signed an MOU to build an AI campus in Seoul this year, promising internships, joint research and closer ties with Samsung and chipmakers.

Qualcomm jumped after analyst Ming‑Chi Kuo said OpenAI is working with Qualcomm and MediaTek on custom phone chips, with Luxshare named as the manufacturer.

Eli Lilly agreed to buy Ajax Therapeutics for up to $2.3 billion, taking on a Cambridge biotech's experimental Type II JAK2 drug for myelofibrosis with data due in 2026.

China’s NDRC ordered the cancellation of Meta’s acquisition of Manus, forcing parties to withdraw and raising new risks for cross‑border AI deals. The move unsettles Bay Area dealmaking.

A Texas A&M team reports a two‑dose nasal spray made from stem cell‑derived vesicles cut brain inflammation and improved memory in older mice.

Cambridge-based Hemab filed to raise $212M in a Nasdaq IPO to advance clinical programs for rare bleeding disorders. The S-1 outlines uses for sutacimig and HMB-002.

A Somerville randomized trial found one month of HEPA filtration sped up executive function by about 12% for adults 40+, though researchers call the result preliminary.

Less than a year after merging, UT San Antonio rose to No. 64 in NIH funding with $147.1M, driven by gains in medicine, dentistry and early cross‑campus seed grants.

Ionic MT says Silicon Ridge holds 16 critical minerals in halloysite clay — a find that could cut U.S. reliance on China and send revenue to Utah schools.

A UCSD‑led read of the 2024 federal drug survey estimates about 8 million Americans used psilocybin last year. Researchers say clinicians should begin screening and offering harm‑reduction counseling.

UChicago professors propose scaling a hands‑on "Tools of Thought" apprenticeship that pairs City Colleges students with Chicago firms to teach the nonroutine skills AI can’t replace.

Large phase‑3 trials show AD109, a once‑nightly pill, cut sleep‑apnea severity by about half; dry mouth and insomnia were common and regulators will review safety.

President Trump abruptly removed members of the National Science Board, stripping an advisory panel that helps govern the NSF and prompting immediate backlash from universities and lawmakers.